NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Company Directory Search

Aceragen Inc.

Aceragen Inc.

Aceragen is a clinical-stage biopharmaceutical company developing therapeutics for rare and orphan pulmonary and rheumatic diseases with high unmet medical need, including a late-stage therapy for Farber disease.

Company Location

15 T.W. Alexander Drive, Suite 418

Research Triangle Park

Company Details

Year founded
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
ACG-801, an enzyme replacement therapy for Farber disease; ACG-701, potent anti-infective & anti-inflammatory treatment for melioidosis & CF-related pulmonary exacerbations